Appleton Partners Incma buys $1,651,356 stake in Pfizer (PFE)

Pfizer (PFE) : Appleton Partners Incma scooped up 434 additional shares in Pfizer during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 49,635 shares of Pfizer which is valued at $1,651,356.Pfizer makes up approximately 0.32% of Appleton Partners Incma’s portfolio.

Pfizer closed down -0.05 points or -0.15% at $33 with 2,60,94,478 shares getting traded on Wednesday. Post opening the session at $32.98, the shares hit an intraday low of $32.9 and an intraday high of $33.21 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Jnba Financial Advisors reduced its stake in PFE by selling 75 shares or 1.08% in the most recent quarter. The Hedge Fund company now holds 6,893 shares of PFE which is valued at $229,330. Pfizer makes up approx 0.08% of Jnba Financial Advisors’s portfolio.Migdal Insurance Financial Holdings Ltd. boosted its stake in PFE in the latest quarter, The investment management firm added 549,650 additional shares and now holds a total of 1,262,638 shares of Pfizer which is valued at $42,007,966. Pfizer makes up approx 1.28% of Migdal Insurance Financial Holdings Ltd.’s portfolio.Narwhal Capital Management boosted its stake in PFE in the latest quarter, The investment management firm added 1,700 additional shares and now holds a total of 125,322 shares of Pfizer which is valued at $4,169,463. Pfizer makes up approx 1.34% of Narwhal Capital Management’s portfolio.Gulf International Bank (uk) Ltd boosted its stake in PFE in the latest quarter, The investment management firm added 23,440 additional shares and now holds a total of 1,857,690 shares of Pfizer which is valued at $61,805,346. Pfizer makes up approx 1.04% of Gulf International Bank (uk) Ltd’s portfolio.Eqis Capital Management reduced its stake in PFE by selling 217 shares or 0.69% in the most recent quarter. The Hedge Fund company now holds 31,353 shares of PFE which is valued at $999,847. Pfizer makes up approx 0.07% of Eqis Capital Management’s portfolio.

On the company’s financial health, Pfizer reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.17 according to the earnings call on Feb 2, 2016. Analyst had a consensus of $0.36. The company had revenue of $14047.00 million for the quarter, compared to analysts expectations of $13595.19 million. The company’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.54 EPS.

Many Wall Street Analysts have commented on Pfizer. Goldman Resumed Pfizer on Apr 18, 2016 to “Neutral”, Price Target of the shares are set at $35.JP Morgan Resumed Pfizer on Apr 7, 2016 to “Overweight”, Price Target of the shares are set at $38.Morgan Stanley Resumed Pfizer on Apr 7, 2016 to “Equal-Weight”, Price Target of the shares are set at $35.

Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in discovering developing and manufacturing of healthcare products. Its products include Lyrica the Prevnar family of products Enbrel Celebrex Lipitor Viagra Zyvox Sutent EpiPen Toviaz Tygacil Rapamune Xalkori Inlyta Norvasc BeneFIX Genotropin and Enbrel among others. It operates in three segments: Global Innovative Pharmaceutical segment (GIP) Global Vaccines Oncology and Consumer Healthcare segment (VOC) and Global Established Pharmaceutical segment (GEP). GIP is focused on developing registering and commercializing medications in therapeutic areas such as inflammation cardiovascular/metabolic neuroscience and pain rare diseases and women’s/men’s health. VOC focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare. GEP includes its sterile injectable products and bio similar development portfolio. Its subsidiary is Hospira Inc.

Leave a Reply

Pfizer - Is it time to Sell?

Top Brokerage Firms are advising their investors on Pfizer. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.